{
  "report_rows": [
    {
      "kpi": "2Q26 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$8.73B vs. cons $8.55B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.41 vs. cons $3.27",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total backlog at 2Q26 end",
      "prediction": "IN-LINE",
      "answer": "pred ~$50.8B vs. cons $50.4B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted diluted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$14.20 vs. cons $14.07 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$35.25B vs. cons $35.05B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA guidance",
      "prediction": "BETTER",
      "answer": "guide ~$3.70B vs. cons $3.64B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 free-cash-flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.80B vs. cons $1.80B (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A revenue and EPS beat paired with a modest FY26 EPS/EBITDA raise implies favorable second-half operating math: the implied 2H adjusted EPS outlook rises to ~$8.12 versus ~$7.99 before the update. In-line backlog limits the initial upside, but continued margin progression and upward out-period estimates should support follow-through rather than a fade.",
  "day5_confidence": "MEDIUM"
}